Descriptive epidemiology of ovarian cancer in the United States, 1992–1997
暂无分享,去创建一个
[1] H. Howe,et al. Pathology and classification of ovarian tumors , 2003, Cancer.
[2] L. Wilkens,et al. Stage at diagnosis of ovarian cancer in the United States, 1992–1997 , 2003, Cancer.
[3] B. Kohler,et al. Multiple primary cancers of the ovary in the United States, 1992–1997 , 2003, Cancer.
[4] H. Howe,et al. Incidence of extraovarian primary cancers in the United States, 1992–1997 , 2003, Cancer.
[5] S. Coughlin,et al. Race/ethnic variations in ovarian cancer mortality in the United States, 1992–1997 , 2003, Cancer.
[6] H. Howe,et al. Ovarian cancer in children and young adults in the United States, 1992–1997 , 2003, Cancer.
[7] H. Howe,et al. Regional variations in ovarian cancer incidence in the United States, 1992–1997 , 2003, Cancer.
[8] S. Coughlin,et al. Incidence of ovarian cancer by race and ethnicity in the United States, 1992–1997 , 2003, Cancer.
[9] Alexander Tsodikov,et al. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? , 2002, Gynecologic oncology.
[10] A. Whittemore,et al. Race, Epithelial Ovarian Cancer Survival, and Membership in a Large Health Maintenance Organization , 2002, Epidemiology.
[11] J. Cerhan,et al. Association of Parity and Ovarian Cancer Risk by Family History of Breast or Ovarian Cancer in a Population-Based Study of Postmenopausal Women , 2002, Epidemiology.
[12] P. Dickman,et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. , 2001, Gynecologic oncology.
[13] R. Ness,et al. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. , 2001, Annals of epidemiology.
[14] H M Rosenberg,et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.
[15] M. Noguchi,et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. , 2000, Cancer research.
[16] J. Gohagan,et al. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. , 2000, Controlled clinical trials.
[17] Daniel S. Miller,et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.
[18] R. Scully. Influence of origin of ovarian cancer on efficacy of screening , 2000, The Lancet.
[19] R. Tarone,et al. Age-period-cohort analyses of breast-, ovarian-, endometrial- and cervical-cancer mortality rates for Caucasian women in the USA. , 2000, Journal of epidemiology and biostatistics.
[20] D. Parkin,et al. The performance of screening tests for ovarian cancer: results of a systematic review , 1999, British journal of obstetrics and gynaecology.
[21] R. Ness,et al. Possible role of ovarian epithelial inflammation in ovarian cancer. , 1999, Journal of the National Cancer Institute.
[22] P. Sorlie,et al. Quality of death rates by race and Hispanic origin: a summary of current research, 1999. , 1999, Vital and health statistics. Series 2, Data evaluation and methods research.
[23] Steven J Skates,et al. Screening for ovarian cancer: a pilot randomised controlled trial , 1999, The Lancet.
[24] T. Sellers,et al. Prospective study of diet and ovarian cancer. , 1999, American journal of epidemiology.
[25] H. Risch. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. , 1999, Journal of the National Cancer Institute.
[26] G. Chenevix-Trench,et al. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer. , 1998, Journal of the National Cancer Institute.
[27] K. Kerlikowske,et al. HORMONE REPLACEMENT THERAPY AND THE RISK OF EPITHELIAL OVARIAN CARCINOMA: A META‐ANALYSIS , 1998, Obstetrics and gynecology.
[28] F. Miller,et al. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. , 1998, Radiology.
[29] G. Parham,et al. The national cancer data base report on malignant epithelial ovarian carcinoma in African‐American women , 1997, Cancer.
[30] A. Berchuck,et al. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. , 1997, Journal of the National Cancer Institute.
[31] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[32] E. Feuer,et al. Confidence intervals for directly standardized rates: a method based on the gamma distribution. , 1997, Statistics in medicine.
[33] H. Risch,et al. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. , 1996, American journal of epidemiology.
[34] M. Janicek,et al. The national cancer data base report on ovarian cancer , 1995, Cancer.
[35] D. Machin. Trends in Cancer Incidence and Mortality , 1995, British Journal of Cancer.
[36] S. Seal,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.
[37] P. Humphrey,et al. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. , 1994, Gynecologic oncology.
[38] J. Morris,et al. Epidemiology and prevention. , 1982, The Milbank Memorial Fund quarterly. Health and society.
[39] S. Orsulic,et al. Ovarian Cancer , 1993, British Journal of Cancer.
[40] J. Mclaughlin,et al. Comparability of the death certificate and the 1986 National Mortality Followback Survey. , 1993, Vital and health statistics. Series 2, Data evaluation and methods research.
[41] H. Hogan. The 1990 Post-Enumeration Survey: operations and results. , 1993, Journal of the American Statistical Association.
[42] C. Johannes,et al. Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women". , 1993, American journal of epidemiology.
[43] A S Whittemore,et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.
[44] A. Whittemore,et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.
[45] D. Cramer,et al. Perineal Exposure to Talc and Ovarian Cancer Risk , 1992, Obstetrics and gynecology.
[46] M. Goodman,et al. Racial variation in cancer incidence: fact or artifact? , 1992, Journal of the National Cancer Institute.
[47] S. Lowry,et al. Incessant ovulation and ovarian cancer , 1991, The Lancet.
[48] P. Wingo,et al. The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists? , 1991, American journal of obstetrics and gynecology.
[49] R. Bast,et al. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. , 1990, Cancer research.
[50] J. Shepherd. Revised FIGO staging for gynaecological cancer , 1989, British journal of obstetrics and gynaecology.
[51] W. Willett,et al. GALACTOSE CONSUMPTION AND METABOLISM IN RELATION TO THE RISK OF OVARIAN CANCER , 1989, The Lancet.
[52] A. Whittemore,et al. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. , 1988, American journal of epidemiology.
[53] A. Whittemore,et al. Errors in reported dietary intakes. II. Long-term recall. , 1988, American journal of epidemiology.
[54] H. Kato,et al. Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80. , 1987, Journal of the National Cancer Institute.
[55] N. Weiss,et al. Epidemiology of borderline ovarian tumors. , 1987, Journal of the National Cancer Institute.
[56] D. Cramer,et al. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. , 1983, Journal of the National Cancer Institute.
[57] H. Stalsberg. An International survey of distributions of histologic types of tumours of the testis and ovary , 1983 .
[58] C. la Vecchia,et al. Risk factors for epithelial ovarian cancer in Italy. , 1982, American journal of epidemiology.
[59] I. Cobden,et al. 初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験 , 1982 .
[60] J. Kelsey,et al. An epidemiologic study of epithelial carcinoma of the ovary. , 1981, American journal of epidemiology.
[61] J. Zajicek. Prevention of ovarian cystomas by inhibition of ovulation: a new concept. , 1978, The Journal of reproductive medicine.
[62] J. Knowelden,et al. Cancer Epidemiology and Prevention , 1976, British Journal of Cancer.
[63] B. Stadel. The etiology and prevention of ovarian cancer , 1975 .
[64] M F Fathalla,et al. Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.
[65] Daan Brandenbarg. The National. , 1892 .
[66] U. G. Dailey. Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.